CClinicalTrials.gg
RecruitingNCT07660393Updated Aug 11, 2026

The Use of Virtual Reality Glasses in Women With Premature Rupture of Membranes

An interventional study of Standard prenatal care and Nature-themed video in Fetal Health Anxiety, Prenatal Distress and Prenatal Attachment, sponsored by Selcuk University. Recruiting at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-11.

Sponsored by Selcuk University · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
176
Allocation
Randomized
Ages
18 Years to 50 Years
Sex
Female
01

Study summary

The Effect of Virtual Reality Glass Use on Fetal Health Anxiety, Prenatal Distress, and Maternal-Fetal Attachment in Women with Premature Rupture of Membranes: A Randomized Controlled Trial

Read the detailed description

This study is a randomized controlled trial. The study population will consist of nulliparous pregnant women hospitalized with a diagnosis of preterm premature rupture of membranes (PPROM) in the Perinatology Clinic of Konya City Hospital between June 2025 and January 2027. A total of 176 pregnant women who will be giving birth for the first time will be included in the study (intervention group: n = 88; control group: n = 88). In the intervention group, pregnant women with PPROM will watch a nature-themed video accompanied by natural sounds selected by the researchers through a virtual reality headset (VRH) twice daily for three consecutive days, with each session lasting at least five minutes. The control group will receive the standard antenatal care provided by the hospital. Data will be collected using a Personal Information Form, the Fetal Health Anxiety Scale, the Prenatal Distress Questionnaire, and the Prenatal Attachment Inventory.

02

Conditions studied

  • Fetal Health Anxiety
  • Prenatal Distress
  • Prenatal Attachment

Keywords

  • Virtual Reality Glasses (VRG)
  • Fetal Health Anxiety
  • Prenatal Distress Scale
  • Prenatal Attachment
03

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • Being 18 years of age or older
  • Being nulliparous
  • Having a diagnosis of preterm premature rupture of membranes (PPROM)
  • Being between 24 and 37 weeks of gestation
  • Having a singleton pregnancy
  • Being hospitalized in the ward for at least 3 days
  • Having no visual or hearing impairment
  • Being communicative and mentally and psychologically healthy
  • Being able to speak and express oneself in Turkish

Exclusion criteria

Exclusion Criteria:

  • Having an additional diagnosis besides preterm premature rupture of membranes (PPROM) (e.g., preeclampsia, fetal distress, fetal anomalies, gestational diabetes, bleeding, etc.)
  • Having a chronic disease (e.g., hypertension, diabetes mellitus, thyroid disorders, etc.)
  • Having conceived through assisted reproductive technologies (ART)
  • Having any skin infection.
04

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
176 participants (estimated)

Study arms

  • Placebo comparator
    Standard prenatal care

    The control group will receive standard prenatal care and treatment provided by the hospital. After the study is completed, control group participants will be shown nature-themed videos via Virtual Reality Glasses (VRG) if they wish.

    Other: Standard prenatal care · Other: Nature-themed video

  • Experimental
    Nature-themed video

    Pregnant women with premise rupture of membranes (PRM) in the intervention group will be shown a nature-themed video prepared by the researchers with nature sounds via Virtual Reality Glasses (VRG) twice a day for at least five minutes each time for three days.

    Other: Nature-themed video

Interventions

  • OtherStandard prenatal care

    The control group will receive standard prenatal care and treatment provided by the hospital. After the study is completed, control group participants will be shown nature-themed videos via Virtual Reality Glasses (VRG) if they wish.

  • OtherNature-themed video

    Pregnant women with premise rupture of membranes (PRM) in the intervention group will be shown a nature-themed video prepared by the researchers with nature sounds via Virtual Reality Glasses (VRG) twice a day for at least five minutes each time for three days.

05

What researchers measure

Primary outcomes

  1. Comparison of sociodemographic characteristics of pregnant women with premature rupture of membranes prior to intervention using questionnaires.

    Sociodemographic information of pregnant women will be collected, compared, and reported through questionnaires.

    Time frame: 6 months

  2. Comparison of mean scores on the Fetal Health Concern Scale among groups of pregnant women.

    The Fetal Health Concern Scale will be administered to pregnant women. The Fetal Health Concern Scale ranges from 0 to 42 points (minimum-maximum), with higher scores indicating greater fetal health concern.

    Time frame: 6 months

  3. Comparison of mean Prenatal Distress Scale scores among groups of pregnant women.

    The Prenatal Distress Scale will be administered to all pregnant women. The Prenatal Distress Scale ranges from 0 to 34 points (minimum-maximum), with higher scores indicating greater prenatal distress.

    Time frame: 6 months

  4. Comparison of mean Prenatal Attachment Inventory scores among groups of pregnant women.

    The Prenatal Attachment Inventory will be administered to all pregnant women. The Prenatal Attachment Inventory score ranges from 21 to 84 points (minimum-maximum), with higher scores indicating greater prenatal distress.

    Time frame: 6 months

06

Study locations

1 of 1 sites recruiting
  • Seyhan Çankaya
    Konya, 42250, Turkey (Türkiye)
    • Seyhan Çankaya, PhD · Contact · seyhane32@gmail.com · 05054300733
    • Seyhan Çankaya, PhD · Principal investigator
    Recruiting
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07660393
Lead sponsor
Selcuk University
Responsible party
Seyhan Çankaya (Assoc. Prof. Seyhan Çankaya, Selcuk University) — Principal investigator
First posted
Jun 22, 2026
Start date
Jun 16, 2026
Primary completion
Jan 1, 2027 (estimated)
Completion
Jan 1, 2027 (estimated)
Last update
Aug 11, 2026

Study contacts

Seyhan Çankaya, PhD
Contact
seyhane32@gmail.com
+905054300733
Seyhan Çankaya, PhD
Contact
sbf@selcuk.edu.tr
+903322233577
Seyhan Çankaya, Phd
study chair · Selcuk University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion